Hashimoto, Teppei
Tsuboi, Kazuyuki
Abe, Takeo
Yoshikawa, Takahiro
Noguchi, Kazuteru
Furukawa, Tetsuya
Tateishi, Koji
Terashima, Yasuhiro
Sibanuma, Nao
Azuma, Naoto
Yamane, Takashi
Matsui, Kiyoshi
Hashiramoto, Akira
Article History
Received: 27 January 2025
Accepted: 8 April 2025
First Online: 17 April 2025
Declarations
:
: This study was approved by the Institutional Ethics Committees of Hyogo Medical University, Kobe City Medical Center West Hospital, Konan (Hakuhoukai), Kakogawa Hospital, and Kobe Kaisei Hospital. All participants signed informed consent forms.
: Not applicable.
: AH: Honoraria from AbbVie G.K., and honoraria and grants from Eli Lilly Japan K.K., Asahikasei Pharma Co. and Chugai Pharmaceutical Co. TY (Takashi Yamane): Honoraria from GlaxoSmithKline K.K. KM: Grants from Asahikasei Pharma Co. and Chugai Pharmaceutical Co. The other authors: No conflicts of interest.